Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies

American Journal of Gastroenterology

Volumn 96, Issue 1, 2001, Pages 58-62

  Perri, Francesco ^a   Festa, Virginia ^a   Clemente, Rocco ^a   Villani, Maria Rosaria ^a   Quitadamo, Michele ^a   Caruso, Nazario ^a   Li Bergoli, Michele ^a   Andriulli, Angelo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CARBON 13; CLARITHROMYCIN; METRONIDAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RIFABUTIN; TETRACYCLINE; UREA;

ADULT; ANAPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPY; FEMALE; GASTROINTESTINAL SYMPTOM; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME; VERTIGO;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BENZIMIDAZOLES; BIOPSY, NEEDLE; CONFIDENCE INTERVALS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PROBABILITY; PROSPECTIVE STUDIES; RIFABUTIN; SULFOXIDES; TETRACYCLINE; TREATMENT FAILURE;

EID: 0035139233     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02245-0     Document Type: Article

References (26)

1. Treatment after failure: The problem of "non-responders."
2. Which combination therapy can eradicate ≥90% Helicobacter pylori infection? A meta-analysis of amoxycillin, metronidazole, tetracycline, and clarithromycin containing regimens
3. Review article: One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori
4. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice
5. Current European concepts in the management of Helicobacter pylori infection
6. Helicobacter pylori consensus: Report of the 1997 Asia Pacific consensus conference on the management of Helicobacter pylori infection
7. Strategy for the re-treatment of failed Helicobacter pylori eradication therapy: A case series
8. Highly effective secondline anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy
9. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: Differing efficacy in previously treated and untreated patients
10. Two different approaches after failure of standard H. pylori eradication triple therapies
11. Which therapy should we use when a previous Helicobacter pylori eradication therapy fails?
12. Maastricht consensus report regimen for second-line treatment of H. pylori infection: How does it perform in practice?
13. Antimicrobial activity of rifabutin
14. In vitro activity of rifabutin, a potential antibiotic in the therapy of Helicobacter pylori
15. Treatment of antibiotic-resistant Helicobacter pylori infection
16. Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens
17. Cresyl-fast violet staining method for Campylobacter-like organisms
18. 13C-urea breath test for the diagnosis of Helicobacter pylori infection
19. What other regimens are under investigation to treat Helicobacter pylori infection?
20. Antimicrobial therapy for Helicobacter pylori infection
21. Re-treatment of Helicobacter pylori infection with amoxycillin and omeprazole in patients failing this regimen is less successful than initial treatment
22. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons
23. Eradication failures significantly change the profile of H. pylori antibiotic resistance: An epidemiological study in Southern Italy
24. Twice a day quadruple therapy (bismuth subsalicilate, tetracycline, metronidazole plus lansoprazole) for treatment of H pylori infection
25. Rifampin and rifabutin resistance mechanism in Helicobacter pylori